Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

mission pharmacal company - ascorbic acid (unii: pq6ck8pd0r) (ascorbic acid - unii:pq6ck8pd0r), iron (unii: e1uol152h7) (iron - unii:e1uol152h7), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), thiamine (unii: x66nso3n35) (thiamine ion - unii:4abt0j945j), niacinamide (unii: 25x51i8rd4) (niacinamide - unii:25x51i8rd4), pyridoxine hydrochloride (unii: 68y4cf58bv) (pyridoxine - unii:kv2jz1bi6z), folic acid (unii: 935e97boy8) (folic acid - unii:935e97boy8), zinc oxide (unii: soi2loh54z) (zinc oxide - unii:soi2loh54z), cupric oxide (unii: v1xjq704r4) (cupric cation - unii:8cbv67279l), docusate sodium (unii: f05q2t2ja0) (docusate - unii:m7p27195ag), calcium citrate (unii: mlm29u2x85) (calcium cation - unii:2m83c4r6zb), thiamine mononitrate (unii: 8k0i04919x) (thiamine ion - unii:4abt0j945j), potassium iodide (unii: 1c4qk22f9j) (iodide ion - unii:09g4i6v86q), ferrous gluconate (unii: u1b11i423z) (ferrous cation - unii:gw89581owr), vitamin d (unii: 9vu1ki44gp) (vitamin d - unii:9vu1ki44gp), riboflavin (unii: tlm2976ofr) (riboflavin - unii:tlm2976ofr) - ascorbic acid 120 mg - citranatal ® 90 dha is a multivitamin/mineral prescription drug indicated for use in improving the nutritional status of women prior to conception, throughout pregnancy, and in the postnatal period for both lactating and nonlactating mothers. this product is contraindicated in patients with a known hypersensitivity to any of the ingredients.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - omega-3-acid ethyl esters 90, quantity: 1000 mg - capsule, soft - excipient ingredients: purified water; gelatin; glycerol; d-alpha-tocopherol - hypertriglyceridaemia: endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response. treatment is indicated for the following types of dyslipidaemia (fredrickson classification) only: -type iv & v as monotherapy and with close monitoring of ldl-c levels. - type iib as add-on therapy to statins, when control of triglycerides with statins has been shown to be insufficient. patients with higher baseline levels of triglycerides are more likely to exhibit a better response to omacor. omacor is not indicated in exogenous hypertriglyceridaemia (type 1 hyperchylomicronaemia). there are insufficient data to support the use in patients with secondary endogenous hypertriglyceridaemia including patients with diabetes mellitus.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

qpharma inc - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s) - omega-3-acid ethyl esters 900 mg - omega-3-acid ethyl esters capsules are indicated as an adjunct to diet to reduce triglyceride (tg) levels in adult patients with severe (greater than or equal to 500 mg/dl) hypertriglyceridemia. usage considerations: patients should be placed on an appropriate lipid-lowering diet before receiving omega-3-acid ethyl esters capsules and should continue this diet during treatment with omega-3-acid ethyl esters capsules. laboratory studies should be done to ascertain that the lipid levels are consistently abnormal before instituting therapy with omega-3-acid ethyl esters capsules. every attempt should be made to control serum lipids with appropriate diet, exercise, weight loss in obese patients, and control of any medical problems such as diabetes mellitus and hypothyroidism that are contributing to the lipid abnormalities. medications known to exacerbate hypertriglyceridemia (such as beta blockers, thiazides, estrogens) should be discontinued or changed, if possible, prior to consideration of tg-lowering drug t

Filipinai - anglų - FDA (Food And Drug Administration)

united laboratories, inc. - eicosapentaenoic acid , docosahexaenoic acid - capsule, soft gelatin - 460mg + 380mg

Kanada - anglų - Health Canada

herbalife international of luxembourg s À r l - eicosapentaenoic acid; docosahexaenoic acid - capsule - 119mg; 78mg - eicosapentaenoic acid 119mg; docosahexaenoic acid 78mg - miscellaneous antilipemic agents

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

seven seas ltd - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 170mg ; 115mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

waymade healthcare plc - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 170mg ; 115mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

dowelhurst ltd - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 170mg ; 115mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

de pharmaceuticals - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 170mg ; 115mg

Didžioji Britanija - anglų - MHRA (Medicines & Healthcare Products Regulatory Agency)

sigma pharmaceuticals plc - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 170mg ; 115mg